Back
Intellia Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
29
NTLA
Intellia Therapeutics
Last Price:
$11.82
Seasonality Move:
-9.64%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NTLA is experiencing selling pressure, which indicates risk of future bearish movement.
Intellia Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.77 | Buy |
| 20-day SMA: | 10.57 | Buy |
| 50-day SMA: | 9.24 | Buy |
| 200-day SMA: | 11.56 | Buy |
| 8-day EMA: | 10.22 | Buy |
| 20-day EMA: | 6.49 | Buy |
| 50-day EMA: | 3.23 | Buy |
| 200-day EMA: | 0.91 | Buy |
Intellia Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.28 | Buy |
| Relative Strength Index (14 RSI): | 64.33 | Buy |
| Chaikin Money Flow: | -2533972 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.96 - 11.44) | Buy |
| Bollinger Bands (100): | (7.5 - 10.36) | Buy |
Intellia Therapeutics Technical Analysis
| Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Intellia Therapeutics Stock
Is Intellia Therapeutics Stock a Buy?
-
Intellia Therapeutics share price is 11.83 while NTLA 8-day simple moving average is 11.77, which is a Buy signal.
-
The stock price of NTLA is 11.83 while Intellia Therapeutics 20-day SMA is 10.57, which makes it a Buy.
-
Intellia Therapeutics 50-day simple moving average is 9.24 while NTLA share price is 11.83, making it a Buy technically.
-
NTLA stock price is 11.83 and Intellia Therapeutics 200-day simple moving average is 11.56, creating a Buy signal.
NTLA Technical Analysis vs Fundamental Analysis
Sell
29
Intellia Therapeutics (NTLA)
is a Sell
Is Intellia Therapeutics a Buy or a Sell?
-
Intellia Therapeutics stock is rated a SellThe current Intellia Therapeutics [NTLA] share price is $11.83. The Score for NTLA is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
Intellia Therapeutics Stock Info
Market Cap:
1.2B
Price in USD:
11.83
Share Volume:
2.8M
Intellia Therapeutics 52-Week Range
52-Week High:
27.77
52-Week Low:
5.90
Sell
29
Intellia Therapeutics (NTLA)
is a Sell
Intellia Therapeutics Share Price Forecast
-
What is the Intellia Therapeutics stock price today?The Intellia Therapeutics stock price is 11.83 USD today.
-
Will NTLA stock go up or go down?Intellia Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Intellia Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Intellia Therapeutics is overvalued.
Is Intellia Therapeutics Stock a Buy?
-
Intellia Therapeutics share price is 11.83 while NTLA 8-day exponential moving average is 10.22, which is a Buy signal.
-
The stock price of NTLA is 11.83 while Intellia Therapeutics 20-day EMA is 6.49, which makes it a Buy.
-
Intellia Therapeutics 50-day exponential moving average is 3.23 while NTLA share price is 11.83, making it a Buy technically.
-
NTLA stock price is 11.83 and Intellia Therapeutics 200-day simple moving average is 0.91, creating a Buy signal.
Fundamental Analysis of Intellia Therapeutics
Is Intellia Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.10 per share, an increase this year of $1.13 per share, and an increase next year of $0.30 per share.
Technical Analysis of Intellia Therapeutics
Should I short Intellia Therapeutics stock?
-
NTLA Moving Average Covergence Divergence (MACD) indicator is 3.28, suggesting Intellia Therapeutics is a Buy
-
Intellia Therapeutics Relative Strength Index (RSI) is 64.33, which suggest Intellia Therapeutics is overbought
-
The Bollinger Bands (25) for Intellia Therapeutics is (8.96 - 11.44), which suggest Intellia Therapeutics is a Buy
-
The Bollinger Bands (100) for Intellia Therapeutics is (7.5 - 10.36), which suggest Intellia Therapeutics is a Buy
* Intellia Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.